Kara Gross Margolis

NYU Grossman School of Medicine

NIH Rank #6989
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#6,989
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 3 grants · National rank #6989.

Top grants by award amount

Kara Gross Margolis's NIH grant portfolio, ranked by award amount.

  • 1R01DK136292-01A1R01
    Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunction
    $692.9K
    award amount
  • 5R01DK130517-04R01
    A Prospective Study Examining the Role of Gestational SSRI Exposure in the Development of Functional Gastrointestinal Disorders
    $582K
    award amount
  • 5R01DK126644-04R01
    Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brain
    $444.8K
    award amount

Affiliation

Institutions that have administered grants for Kara Gross Margolis.

Affiliated with NYU Grossman School of Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6989